GenFleet Therapeutics (Shanghai) Inc is a biopharmaceutical company focused on developing novel treatment options in the fields of oncology, covering different lines of treatments of multiple solid… Genfleet (HKG: 02595) is based in Shanghai, China and was founded in 2017. It is now publicly traded; this page covers its private-market history, where its last recorded valuation was $800 million (Sep 2025). It has raised $205 million.
Last price · $/share
—
Implied valuation
$799.7M
Total raised
$204.8M
Last round
—
Team — not yet on record
No current team members for Genfleet (HKG: 02595) are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Genfleet (HKG: 02595) with a free account
·Watch Genfleet (HKG: 02595): the Monday email on marks, rounds and moves
